Literature DB >> 21613573

Structural analysis of vascular endothelial growth factor receptor-2/ligand complexes by small-angle X-ray solution scattering.

Kaisa Kisko1, Maurice S Brozzo, John Missimer, Thomas Schleier, Andreas Menzel, Veli-Matti Leppänen, Kari Alitalo, Thomas Walzthoeni, Ruedi Aebersold, Kurt Ballmer-Hofer.   

Abstract

Receptor tyrosine kinases play essential roles in tissue development and homeostasis, and aberrant signaling by these molecules is the basis of many diseases. Understanding the activation mechanism of these receptors is thus of high clinical relevance. We investigated vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs), which regulate blood and lymph vessel formation. We analyzed the structural changes in the extracellular receptor domain that were induced by ligand binding and that represent the initial step in transmembrane signaling, culminating in the activation of the intracellular receptor kinase domain. High-resolution structural information for the ligand binding domain became available recently, but the flexibility of the extracellular domain and inhomogeneous glycosylation of VEGFRs have prevented the production of highly diffracting crystals of the entire extracellular domain so far. Therefore, we chose to further investigate VEGFR structure by small-angle X-ray scattering in solution (SAXS). SAXS data were combined with independent distance restraint determination obtained by mass spectrometric analysis of chemically cross-linked ligand/receptor complexes. With these data, we constructed a structural model of the entire extracellular receptor domain in the unbound form and in complex with VEGF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613573     DOI: 10.1096/fj.11-185397

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.

Authors:  Caroline A C Hyde; Alexandra Giese; Edward Stuttfeld; Johan Abram Saliba; Denis Villemagne; Thomas Schleier; H Kaspar Binz; Kurt Ballmer-Hofer
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

3.  Cooperative interactions between VEGFR2 extracellular Ig-like subdomains ensure VEGFR2 dimerization.

Authors:  Christopher King; Daniel Wirth; Samuel Workman; Kalina Hristova
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-25       Impact factor: 3.770

4.  Lysine-specific chemical cross-linking of protein complexes and identification of cross-linking sites using LC-MS/MS and the xQuest/xProphet software pipeline.

Authors:  Alexander Leitner; Thomas Walzthoeni; Ruedi Aebersold
Journal:  Nat Protoc       Date:  2013-12-19       Impact factor: 13.491

5.  Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7.

Authors:  Rossella Di Stasi; Donatella Diana; Lucia De Rosa; Roberto Fattorusso; Luca D D'Andrea
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

6.  Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.

Authors:  Kevin Brown Chandler; Deborah R Leon; Rosana D Meyer; Nader Rahimi; Catherine E Costello
Journal:  J Proteome Res       Date:  2016-12-29       Impact factor: 4.466

Review 7.  Joining forces: integrating proteomics and cross-linking with the mass spectrometry of intact complexes.

Authors:  Florian Stengel; Ruedi Aebersold; Carol V Robinson
Journal:  Mol Cell Proteomics       Date:  2011-12-16       Impact factor: 5.911

Review 8.  Profile of conbercept in the treatment of neovascular age-related macular degeneration.

Authors:  Xinmin Lu; Xiaodong Sun
Journal:  Drug Des Devel Ther       Date:  2015-04-22       Impact factor: 4.162

9.  Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation.

Authors:  Veli-Matti Leppänen; Denis Tvorogov; Kaisa Kisko; Andrea E Prota; Michael Jeltsch; Andrey Anisimov; Sandra Markovic-Mueller; Edward Stuttfeld; Kenneth N Goldie; Kurt Ballmer-Hofer; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

10.  Toroidal-spiral particles for codelivery of anti-VEGFR-2 antibody and irinotecan: a potential implant to hinder recurrence of glioblastoma multiforme.

Authors:  Vishal Sharma; Melanie Köllmer; Magdalena Szymusiak; Ludwig C Nitsche; Richard A Gemeinhart; Ying Liu
Journal:  Biomacromolecules       Date:  2014-02-11       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.